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Invasive fungal infections are associated with significant 
morbidity and mortality despite advances in medical care. 
Aggressive diagnostic approaches in “at risk” patients, cou-
pled with prompt antifungal therapy, are essential for pa-
tient survival. Early intervention is strongly recommended, 
rather than waiting for microbiological or histopathological 
confirmation. The selection of antifungal agents depends on 
the severity of the illness, the most likely infecting pathogen 
and its antifungal susceptibility, any prior exposure to anti-
fungal agents, drug toxicity, and the presence of organ 
dysfunction, as well as all available knowledge regarding the 
use of a particular drug in the given patient population. 
Antifungal agents should be used rationally. De-escalation of 
empirical therapy based on clinical response and laboratory 
results is important to avoid the selection of antifungal 
resistance and the unnecessary use of medical resources.
Over the last 3 years, more antifungal agents have be-
come available and new evidence has accumulated, and so 
these guidelines have been updated accordingly. The aim 
of this document is to provide national guidance on improv-
ing the use of antifungal agents. Three principles provided 
the framework for these guidelines:
1. The Guidelines should be based on academic principles, 
rather than the regulations of the Bureau of National 
Health Insurance on antibiotic usage. The majority of 
recommendations should be evidence-based, encompass-
ing randomized controlled clinical trials and other study 
results, case reports and expert opinion. Also, the Guide-
lines should follow the main structure of similar docu-
ments produced by the Infec tious Diseases Society of 
America.
2. The Guidelines should be based on the local epidemiology 
and susceptibility patterns of pathogens. The heterogeneity 
Guideline
Guidelines for the Use of Antifungal Agents in Patients with 
Invasive Fungal Infections in Taiwan — Revised 2009
The Infectious Diseases Society of Taiwan; The Hematology Society of Taiwan; Taiwan Society of Pulmonary and Critical Care 
Medicine; Medical Foundation in Memory of Dr Deh-Lin Cheng; Foundation of Professor Wei-Chuan Hsieh for Infectious Diseases 
Research and Education; and CY Lee’s Research Foundation for Pediatric Infectious Diseases and Vaccines.
of the patient population and clinical practice should also 
be taken into consideration.
3. The antimicrobial agents recommended in the guidelines 
should be available in Taiwan. These guidelines are ap-
proved by: the board of The Infectious Diseases Society of 
Taiwan, The Hematology Society of Taiwan, and The 
Taiwan Society of Pulmonary and Critical Care Medicine. 
The guidelines are published in the Journal of Microbiology, 
Immunology and Infection and are also available on the 
Society website. These guidelines will be updated and re-
vised as necessary to serve as an easily accessible reference 
to all physicians in Taiwan.
Consensus conference participants 
Chang-Fang Chiu, Cheng-Hua Huang, Cheng-Hwai Tzeng, 
Cheng-Shyong Chang, Cheng-Yi Liu, Chieh-Liang Wu, Chien-
Ching Hung, Ching-Chuan Liu, Ching-Tai Huang, Chin-Yun 
Lee, Chong-Jen Yu, Chung-Chi Huang, Chun-Ming Lee, Feng-
Yee Chang, Fu-Der Wang, Fu-Yuan Huang, Giun-Yi Hung, 
Hsiang-Chi Kung, Hsi-Hsun Lin, Hwei-Fang Tien, Jiann-
Shiuh Chen, Jih-Luh Tang, Ji-Hsiung Young, Johnson Lin, 
Kuang-Yao Yang, Kuo-Chin Kao, Kwen-Tay Luh, Lee-Yung 
Shih, Liang-Tsai Hsiao, Lih-Shinn Wang, Li-Min Huang, Ming-
Chih Chang, Muh-Yong Yen, Ping-Ing Lee, Po Dunn, Po-Min 
Chen, Po-Ren Hsueh, Po-Yen Chen, Po-Yen Huang, Shan-
Chwen Chang, Sheng-Fung Lin, Shih-Chi Ku, Su-Pen Yang, 
Szu-Min Hsieh, Tsai-Yun Chen, Tsu-Yi Chao, Tzeon-Jye Chiou, 
Tzou-Yien Lin, Wei-Chuan Hsieh, Wei-Shou Hwang, Wei-Ting 
Chen, Wen-Chien Ko, Wen-Li Hwang, Wen-Sen Lee, Wing-Wai 
Wong, Woei-Yau Kao, Yee-Chun Chen, Yeu-Chin Chen, Yeu-
Jun Lau, Yhu-Chering Huang, Yin-Ching Chuang, Ying-Huang 
Tsai, Yuan-Bin Yu, Yu-Jiun Chan, Yung-Ching Liu. 
 259
D
ia
gn
os
is
D
ru
gs
 o
f c
ho
ic
e
A
lt
er
na
tiv
es
a
C
om
m
en
ts
1.
 C
an
di
de
m
ia
Em
pi
ric
al
 th
er
ap
y 
sh
ou
ld
 b
e 
co
ns
id
er
ed
 fo
r c
rit
ic
al
ly
 il
l p
at
ie
nt
s 
w
ith
 m
ul
tip
le
 ri
sk
 fa
ct
or
sb
 
fo
r i
nv
as
iv
e 
ca
nd
id
ia
si
s 
an
d 
no
 o
th
er
 k
no
w
n 
ca
us
e 
of
 fe
ve
r.
 R
e-
ev
al
ua
te
 a
nd
 m
od
ify
 
(o
r d
is
co
nt
in
ue
) 
an
tif
un
ga
l a
ge
nt
 4
8–
72
 h
r l
at
er
.
O
ph
th
al
m
os
co
pi
c 
ex
am
in
at
io
n 
is
 r
ec
om
m
en
de
d 
fo
r a
ll 
ca
se
s.
Fo
llo
w
-o
n 
bl
oo
d 
cu
ltu
re
s 
sh
ou
ld
 b
e 
do
ne
 a
ft
er
 4
8–
72
 h
r o
f a
nt
ifu
ng
al
 th
er
ap
y 
(b
ef
or
e 
ne
xt
 d
os
e)
.
Fo
r c
an
di
de
m
ia
 w
ith
ou
t m
et
as
ta
tic
 c
om
pl
ic
at
io
ns
, t
re
at
 1
4 
d 
af
te
r t
he
 f
ir
st
 n
eg
at
iv
e 
bl
oo
d 
cu
ltu
re
 r
es
ul
t a
nd
 r
es
ol
ut
io
n 
of
 s
ig
ns
 a
nd
 s
ym
pt
om
s 
as
so
ci
at
ed
 w
ith
 c
an
di
de
m
ia
.
A
m
B
-d
 is
 th
e 
tr
ea
tm
en
t o
f c
ho
ic
e 
in
 p
re
gn
an
t w
om
en
.
N
on
-n
eu
tr
op
en
ic
R
em
ov
e 
al
l i
nt
ra
va
sc
ul
ar
 c
at
he
te
rs
, i
f p
os
si
bl
e.
Em
pi
ric
al
 th
er
ap
y
A
m
B
-d
;c
fl
uc
on
az
ol
e;
d
ec
hi
no
ca
nd
in
e
L-
A
m
B
;f
vo
ric
on
az
ol
eg
 
Fa
vo
r f
lu
co
na
zo
le
 fo
r p
at
ie
nt
s 
w
ho
 a
re
 le
ss
 c
rit
ic
al
ly
 il
l w
ith
 n
o 
hi
st
or
y 
of
 re
ce
nt
 a
zo
le
 e
xp
os
ur
e.
Fa
vo
r a
n 
ec
hi
no
ca
nd
in
 fo
r p
at
ie
nt
s 
w
ith
 m
od
er
at
e 
to
 s
ev
er
e 
ill
ne
ss
 o
r t
ho
se
 w
ith
 a
 h
is
to
ry
 o
f 
re
ce
nt
 a
zo
le
 e
xp
os
ur
e,
 o
r t
ho
se
 w
ho
 a
re
 a
t h
ig
h 
ris
k 
of
 in
fe
ct
io
n 
du
e 
to
 C
. g
la
br
at
a 
or
 C
. k
ru
se
i.
D
ef
in
iti
ve
 th
er
ap
y
A
m
B
-d
;
Fl
uc
on
az
ol
e;
Ec
hi
no
ca
nd
in
L-
A
m
B
;
Vo
ric
on
az
ol
e
Tr
an
sf
er
 p
at
ie
nt
s 
w
ho
 h
av
e 
is
ol
at
es
 th
at
 a
re
 li
ke
ly
 to
 b
e 
su
sc
ep
tib
le
 to
 f
lu
co
na
zo
le
 
(e
.g
. C
an
di
da
 a
lb
ica
ns
) 
an
d 
w
ho
 a
re
 c
lin
ic
al
ly
 s
ta
bl
e 
fr
om
 a
n 
ec
hi
no
ca
nd
in
 to
 f
lu
co
na
zo
le
.
U
se
 v
or
ic
on
az
ol
e 
as
 a
 s
te
p-
do
w
n 
or
al
 th
er
ap
y 
fo
r s
el
ec
te
d 
ca
se
s 
of
 c
an
di
di
as
is
 d
ue
 to
 
C
. k
ru
se
i o
r v
or
ic
on
az
ol
e-
su
sc
ep
tib
le
 C
. g
la
br
at
a.
C
. p
ar
ap
sil
os
is
Fl
uc
on
az
ol
e;
 
A
m
B
-d
L-
A
m
B
; v
or
ic
on
az
ol
e;
ec
hi
no
ca
nd
in
j
If 
an
 e
ch
in
oc
an
di
n 
is
 u
se
d 
in
iti
al
ly
, c
on
si
de
r c
ha
ng
in
g 
to
 f
lu
co
na
zo
le
.
C
. g
la
br
at
a
A
m
B
-d
 0
.7
–1
.0
 m
g/
kg
/d
;
ec
hi
no
ca
nd
in
;
Fl
uc
on
az
ol
e;
 L
-A
m
B
C
on
tin
ue
 f
lu
co
na
zo
le
 fo
r p
at
ie
nt
s 
w
ho
 a
re
 c
lin
ic
al
ly
 im
pr
ov
ed
, a
nd
 w
ho
se
 fo
llo
w
-u
p 
cu
ltu
re
 re
su
lts
 a
re
 n
eg
at
iv
e.
C
ha
ng
in
g 
to
 f
lu
co
na
zo
le
 o
r v
or
ic
on
az
ol
e 
is
 n
ot
 r
ec
om
m
en
de
d 
w
ith
ou
t c
on
fi
rm
at
io
n 
of
 
is
ol
at
e 
su
sc
ep
tib
ili
ty
. 
C
. k
ru
se
i
Ec
hi
no
ca
nd
in
;
vo
ric
on
az
ol
e
L-
A
m
B
; A
m
B
-d
N
eu
tr
op
en
ia
Th
e 
co
m
m
en
ts
 d
es
cr
ib
ed
 h
er
e 
ar
e 
lim
it
ed
 to
 th
os
e 
sp
ec
if
ic
 fo
r n
eu
tr
op
en
ia
. I
nt
ra
ve
no
us
 
ca
th
et
er
 r
em
ov
al
 is
 a
dv
is
ed
, b
ut
 is
 c
on
tr
ov
er
si
al
.
Fo
r c
an
di
de
m
ia
 w
ith
ou
t p
er
si
st
en
t f
un
ge
m
ia
 o
r m
et
as
ta
tic
 c
om
pl
ic
at
io
ns
, t
re
at
 fo
r 2
 w
k 
af
te
r t
he
 f
ir
st
 n
eg
at
iv
e 
bl
oo
d 
cu
ltu
re
 r
es
ul
t a
nd
 r
es
ol
ut
io
n 
of
 s
ym
pt
om
s 
at
tr
ib
ut
ab
le
 to
 
ca
nd
id
em
ia
, a
nd
 r
es
ol
ut
io
n 
of
 n
eu
tr
op
en
ia
. 
Em
pi
ric
al
 th
er
ap
y
A
m
B
-d
 0
.7
–1
.0
 m
g/
kg
/d
 iv
;
ec
hi
no
ca
nd
in
 
L-
A
m
B
;
fl
uc
on
az
ol
e;
vo
ric
on
az
ol
e;
itr
ac
on
az
ol
eh
 
Fl
uc
on
az
ol
e 
lim
it
ed
 to
 p
at
ie
nt
s 
w
ho
 a
re
 le
ss
 c
rit
ic
al
ly
 il
l, 
w
ith
 n
o 
re
ce
nt
 a
zo
le
 e
xp
os
ur
e,
 
an
d 
ar
e 
un
lik
el
y 
to
 h
av
e 
a 
m
ol
d 
in
fe
ct
io
n.
Vo
ric
on
az
ol
e 
us
ed
 if
 a
dd
iti
on
al
 m
ol
d 
co
ve
ra
ge
 is
 d
es
ir
ed
.
Li
m
it
ed
 d
at
a 
av
ai
la
bl
e 
fo
r m
ic
af
un
gi
n 
an
d 
an
id
ul
af
un
gi
n.
(C
on
td
)
260
D
ia
gn
os
is
D
ru
gs
 o
f c
ho
ic
e
A
lt
er
na
tiv
es
a
C
om
m
en
ts
N
eo
na
ta
l 
ca
nd
id
ia
si
s
A
m
B
-d
 1
.0
 m
g/
kg
/d
; f
lu
co
na
zo
le
 
12
 m
g/
kg
/d
L-
A
m
B
; e
ch
in
oc
an
di
n
A
 lu
m
ba
r p
un
ct
ur
e 
an
d 
op
ht
ha
lm
os
co
pi
c 
ex
am
in
at
io
n 
ar
e 
re
co
m
m
en
de
d 
in
 n
eo
na
te
s 
w
ith
 s
te
ril
e 
bo
dy
 a
nd
/o
r u
rin
e 
cu
ltu
re
s 
po
si
tiv
e 
fo
r C
an
di
da
.
Im
ag
in
g 
of
 th
e 
ge
ni
to
ur
in
ar
y 
tr
ac
t,
 li
ve
r,
 a
nd
 s
pl
ee
n 
sh
ou
ld
 b
e 
pe
rf
or
m
ed
 if
 th
e 
re
su
lts
 o
f 
st
er
ile
 b
od
y 
fl
ui
d 
cu
ltu
re
s 
ar
e 
pe
rs
is
te
nt
ly
 p
os
iti
ve
.
Fo
r c
an
di
de
m
ia
 w
ith
ou
t p
er
si
st
en
t f
un
ge
m
ia
 o
r m
et
as
ta
tic
 c
om
pl
ic
at
io
ns
, t
re
at
 fo
r 3
 w
k.
 
If 
ur
in
ar
y 
tr
ac
t i
nv
ol
ve
m
en
t i
s 
ex
cl
ud
ed
, L
-A
m
B
 c
an
 b
e 
us
ed
.
Li
m
it
ed
 d
at
a 
av
ai
la
bl
e 
fo
r a
ni
du
la
fu
ng
in
.
C
hr
on
ic
 d
is
se
m
in
at
ed
 
ca
nd
id
ia
si
s
Fl
uc
on
az
ol
e;
A
m
B
-d
L-
A
m
B
;
ec
hi
no
ca
nd
in
; 
(v
or
ic
on
az
ol
e)
Tr
ea
tm
en
t s
ho
ul
d 
be
 c
on
tin
ue
d 
un
til
 le
si
on
s 
ha
ve
 r
es
ol
ve
d 
(3
–6
 m
o)
. F
lu
co
na
zo
le
 
(o
r v
or
ic
on
az
ol
e 
in
 s
el
ec
te
d 
si
tu
at
io
ns
) 
ca
n 
be
 u
se
d 
as
 a
 s
te
p-
do
w
n 
th
er
ap
y 
in
 s
ta
bl
e 
pa
tie
nt
s.
C
N
S 
ca
nd
id
ia
sis
A
m
B
-d
 w
ith
 o
r 
w
ith
ou
t 5
-F
C
;i  
fl
uc
on
az
ol
e 
40
0–
80
0 
m
g 
(6
–1
2 
m
g/
kg
) 
da
ily
 fo
r 
pa
tie
nt
s 
un
ab
le
 to
 
to
le
ra
te
 A
m
B
-d
L-
A
m
B
 w
ith
 o
r 
w
ith
ou
t 5
-F
C
;I  
vo
ric
on
az
ol
e
Th
e 
re
m
ov
al
 o
f i
nt
ra
ve
nt
ric
ul
ar
 d
ev
ic
es
 is
 r
ec
om
m
en
de
d.
Tr
ea
t u
nt
il 
al
l s
ig
ns
 a
nd
 s
ym
pt
om
s,
 C
SF
 a
bn
or
m
al
iti
es
, a
nd
 r
ad
io
lo
gi
c 
ab
no
rm
al
iti
es
 h
av
e 
re
so
lv
ed
.
Fl
uc
on
az
ol
e 
(o
r v
or
ic
on
az
ol
e 
in
 s
el
ec
te
d 
si
tu
at
io
ns
) 
ca
n 
be
 u
se
d 
as
 a
 s
te
p-
do
w
n 
th
er
ap
y 
in
 s
ta
bl
e 
pa
tie
nt
s.
C
an
di
da
 e
nd
op
ht
ha
lm
iti
s
A
m
B
-d
 0
.7
–1
 m
g/
kg
 
w
ith
 5
-F
C
; f
lu
co
na
-
zo
le
 6
–1
2 
m
g/
kg
L-
A
m
B
;
vo
ric
on
az
ol
e;
ec
hi
no
ca
nd
in
 
D
ia
gn
os
tic
 v
itr
ea
l a
sp
ir
at
io
n 
sh
ou
ld
 b
e 
do
ne
 if
 th
e 
et
io
lo
gy
 is
 u
nk
no
w
n.
Su
rg
ic
al
 in
te
rv
en
tio
n 
fo
r p
at
ie
nt
s 
w
ith
 s
ev
er
e 
en
do
ph
th
al
m
iti
s 
or
 v
itr
ei
tis
.
D
ur
at
io
n 
of
 th
er
ap
y 
is
 a
t l
ea
st
 4
–6
 w
k,
 d
et
er
m
in
ed
 b
y 
re
pe
at
ed
 e
xa
m
in
at
io
ns
 to
 v
er
ify
 re
so
lu
tio
n.
 
U
rin
ar
y 
tr
ac
t i
nf
ec
tio
n
A
sy
m
pt
om
at
ic 
cy
st
iti
s
Th
er
ap
y 
no
t u
su
al
ly
 
ne
ed
ed
El
im
in
at
io
n 
of
 p
re
di
sp
os
in
g 
fa
ct
or
s 
re
co
m
m
en
de
d.
Fo
r h
ig
h-
ris
k 
su
rg
ic
al
 p
at
ie
nt
s,
 n
eo
na
te
s,
 o
r n
eu
tr
op
en
ic
 p
at
ie
nt
s,
 tr
ea
t a
s 
fo
r 
di
ss
em
in
at
ed
 c
an
di
di
as
is
.
Fo
r p
at
ie
nt
s 
un
de
rg
oi
ng
 u
ro
lo
gi
c 
pr
oc
ed
ur
es
, t
re
at
 w
ith
 f
lu
co
na
zo
le
 b
ef
or
e 
an
d 
af
te
r t
he
 
pr
oc
ed
ur
e.
Sy
m
pt
om
at
ic 
cy
st
iti
s
Fl
uc
on
az
ol
e 
20
0 
m
g 
(3
 m
g/
kg
) 
da
ily
 fo
r 1
4 
d
A
m
B
-d
 0
.3
–0
.6
 m
g/
kg
/d
 
fo
r 7
–1
4 
d
A
m
B
-d
 b
la
dd
er
 ir
rig
at
io
n 
lim
it
ed
 to
 p
at
ie
nt
s 
w
ith
 r
ef
ra
ct
or
y 
fl
uc
on
az
ol
e-
re
si
st
an
t 
or
ga
ni
sm
s 
(e
.g
. C
. k
ru
se
i a
nd
 C
. g
la
br
at
a)
.
Py
el
on
ep
hr
iti
s
Fl
uc
on
az
ol
e 
20
0–
40
0 
m
g 
(3
–6
 m
g/
kg
) 
da
ily
 fo
r 1
4 
d
A
m
B
-d
 w
ith
 o
r w
ith
ou
t 
5-
FC
 fo
r 7
–1
4 
d
Tr
ea
t a
s 
ca
nd
id
em
ia
 fo
r p
at
ie
nt
s 
w
ith
 p
ye
lo
ne
ph
rit
is
 a
nd
 s
us
pe
ct
ed
 d
is
se
m
in
at
ed
 
ca
nd
id
ia
si
s.
M
uc
oc
ut
an
eo
us
 
ca
nd
id
ia
si
s
 261
O
ro
ph
ar
yn
ge
al
N
ys
ta
tin
 s
us
pe
ns
io
n 
20
0,
00
0–
40
0,
00
0 
U
 
qi
d;
fl
uc
on
az
ol
e 
10
0–
20
0 
m
g/
d 
po
It
ra
co
na
zo
le
 2
00
 m
g/
d 
po
;
A
m
B
-d
 0
.3
 m
g/
kg
/d
;
ec
hi
no
ca
nd
in
; 
vo
ric
on
az
ol
e
Tr
ea
t f
or
 7
–1
4 
d 
(1
–7
 d
ay
s 
in
 c
hi
ld
re
n)
 fo
r u
nc
om
pl
ic
at
ed
 d
is
ea
se
.
Es
op
ha
ge
al
Fl
uc
on
az
ol
e 
20
0–
40
0 
m
g/
d;
ec
hi
no
ca
nd
in
;
A
m
B
-d
 0
.3
–0
.7
 m
g/
kg
/d
 iv
 
It
ra
co
na
zo
le
 
20
0 
m
g/
d 
po
;
vo
ric
on
az
ol
e 
Tr
ea
t f
or
 1
4–
21
 d
 u
nt
il 
cl
in
ic
al
 im
pr
ov
em
en
t i
s 
se
en
.
C
an
di
da
 is
ol
at
ed
 fr
om
 
re
sp
ira
to
ry
 se
cr
et
io
ns
Th
er
ap
y 
no
t 
re
co
m
m
en
de
d.
Lo
w
er
 r
es
pi
ra
to
ry
 tr
ac
t C
an
di
da
 in
fe
ct
io
n 
is
 r
ar
e 
an
d 
re
qu
ire
s 
hi
st
op
at
ho
lo
gi
c 
ev
id
en
ce
 to
 
co
nf
irm
 th
e 
di
ag
no
si
s.
2.
  In
va
si
ve
 a
sp
er
gi
llo
si
s
Tr
ea
t u
nt
il 
re
so
lu
tio
n 
or
 s
ta
bi
liz
at
io
n 
of
 a
ll 
cl
in
ic
al
 a
nd
 r
ad
io
gr
ap
hi
c 
m
an
ife
st
at
io
ns
. 
O
th
er
 fa
ct
or
s 
in
cl
ud
e 
si
te
 o
f i
nf
ec
tio
n 
(e
.g
. o
st
eo
m
ye
lit
is
),
 le
ve
l o
f i
m
m
un
os
up
pr
es
si
on
, 
an
d 
ex
te
nt
 o
f d
is
ea
se
. R
ev
er
sa
l o
f i
m
m
un
os
up
pr
es
si
on
, i
f f
ea
si
bl
e,
 is
 im
po
rt
an
t f
or
 a
 fa
vo
-
ra
bl
e 
ou
tc
om
e 
fo
r i
nv
as
iv
e 
as
pe
rg
ill
os
is
.
Em
pi
ric
al
 th
er
ap
y 
A
m
B
 0
.7
–1
.0
 m
g/
kg
/d
;
ec
hi
no
ca
nd
in
;
L-
A
m
B
 3
 m
g/
kg
/d
Vo
ric
on
az
ol
e;
 
It
ra
co
na
zo
le
In
iti
at
io
n 
or
 m
od
if
ic
at
io
n 
of
 a
n 
an
tif
un
ga
l r
eg
im
en
 fo
r p
at
ie
nt
s 
w
ith
 p
er
si
st
 fe
br
ile
 
ne
ut
ro
pe
ni
a 
(g
en
er
al
ly
 4
–7
 d
 in
 d
ur
at
io
n)
 th
at
 is
 w
ith
ou
t a
 k
no
w
n 
so
ur
ce
 a
nd
 is
 
un
re
sp
on
si
ve
 to
 a
pp
ro
pr
ia
te
 a
nt
ib
ac
te
ria
l a
ge
nt
s.
N
o 
da
ta
 a
va
ila
bl
e 
fo
r m
ic
af
un
gi
n 
an
d 
an
id
ul
af
un
gi
n.
Pr
e-
em
pt
iv
e 
th
er
ap
y
A
m
B
-d
;
vo
ric
on
az
ol
e;
L-
A
m
B
ec
hi
no
ca
nd
in
;
itr
ac
on
az
ol
e
In
iti
at
e 
or
 m
od
ify
 a
nt
ifu
ng
al
 th
er
ap
y 
to
 tr
ea
t s
us
pe
ct
ed
 e
ar
ly
 in
va
si
ve
 fu
ng
al
 d
is
ea
se
, 
bu
t u
se
 r
ad
io
lo
gi
c 
st
ud
ie
s,
 la
bo
ra
to
ry
 m
ar
ke
rs
, o
r b
ot
h 
(r
at
he
r t
ha
n 
fe
ve
r a
lo
ne
) 
to
 
st
ra
tif
y 
th
e 
lik
el
ih
oo
d 
of
 a
n 
in
va
si
ve
 fu
ng
al
 in
fe
ct
io
n.
Fa
vo
r A
m
B
-d
 fo
r p
at
ie
nt
s 
at
 ri
sk
 o
f i
nv
as
iv
e 
zy
go
m
yc
os
is
.
Fa
vo
r v
or
ic
on
az
ol
e 
w
he
n 
ra
di
ol
og
ic
al
 p
re
se
nt
at
io
ns
 a
re
 c
on
si
st
en
t w
ith
 in
va
si
ve
 
as
pe
rg
ill
os
is
, a
lo
ng
 w
ith
 a
 p
os
iti
ve
 g
al
ac
to
m
an
na
n 
an
tig
en
.
N
o 
da
ta
 a
va
ila
bl
e 
fo
r a
ni
du
la
fu
ng
in
.
D
ef
in
iti
ve
 th
er
ap
y
Pu
lm
on
ar
y 
an
d 
tr
ac
he
ob
ro
nc
hi
al
Vo
ric
on
az
ol
e;
A
m
B
-d
 
L-
A
m
B
;
ec
hi
no
ca
nd
in
;
itr
ac
on
az
ol
eh
Su
rg
ic
al
 in
te
rv
en
tio
n 
fo
r p
ul
m
on
ar
y 
le
si
on
 in
 p
ro
xi
m
ity
 to
 g
re
at
 v
es
se
ls
 o
r p
er
ic
ar
di
um
, 
in
va
si
on
 o
f c
he
st
 w
al
l f
ro
m
 c
on
tig
uo
us
 p
ul
m
on
ar
y 
le
si
on
, e
m
ph
ys
em
a,
 a
nd
 p
er
si
st
en
t 
he
m
op
ty
si
s 
fr
om
 a
 s
in
gl
e 
ca
vi
ta
ry
 le
si
on
.
N
o 
da
ta
 a
va
ila
bl
e 
fo
r a
ni
du
la
fu
ng
in
.
C
N
S
Vo
ric
on
az
ol
e;
L-
A
m
B
A
m
B
-d
; e
ch
in
oc
an
di
n;
 
itr
ac
on
az
ol
e
Su
rg
ic
al
 r
es
ec
tio
n 
of
 th
e 
in
fe
ct
ed
 ti
ss
ue
 if
 p
os
si
bl
e.
B
ew
ar
e 
of
 d
ru
g 
in
te
ra
ct
io
n 
be
tw
ee
n 
an
tic
on
vu
ls
an
t t
he
ra
py
 a
nd
 v
or
ic
on
az
ol
e.
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td
)
262
D
ia
gn
os
is
D
ru
gs
 o
f c
ho
ic
e
A
lt
er
na
tiv
es
a
C
om
m
en
ts
Si
nu
s, 
en
do
ca
rd
iti
s,
 
os
te
om
ye
lit
is,
 sk
in
 
an
d 
so
ft
 ti
ss
ue
 
in
fe
ct
io
n
Vo
ric
on
az
ol
e;
A
m
B
-d
L-
A
m
B
;
ec
hi
no
ca
nd
in
;
itr
ac
on
az
ol
eh
Su
rg
ic
al
 in
te
rv
en
tio
n 
if 
po
ss
ib
le
.
C
hr
on
ic 
ca
vi
ta
ry
 p
ul
m
on
ar
y 
as
pe
rg
ill
os
is
It
ra
co
na
zo
le
;h
 
vo
ric
on
az
ol
e 
–
O
ra
l t
he
ra
py
A
sp
er
gi
llo
m
a
–
–
Su
rg
ic
al
 r
es
ec
tio
n 
un
de
r s
om
e 
ci
rc
um
st
an
ce
s.
3.
  In
va
si
ve
 z
yg
om
yc
os
is
 
C
N
S
L-
A
m
B
A
m
B
-d
 
Su
rg
ic
al
 r
es
ec
tio
n 
of
 th
e 
in
fe
ct
ed
 ti
ss
ue
 is
 m
an
da
to
ry
.
O
th
er
s
A
m
B
-d
L-
A
m
B
A
gg
re
ss
iv
e 
er
ad
ic
at
in
g 
su
rg
er
y 
is
 m
an
da
to
ry
.
H
ig
h 
do
se
 c
an
 b
e 
co
ns
id
er
ed
 w
he
n 
su
rg
ic
al
 in
te
rv
en
tio
n 
is
 n
ot
 fe
as
ib
le
.
4.
  In
va
si
ve
 C
ry
pt
oc
oc
co
si
s
Fo
r A
ID
S,
 s
ta
rt
 H
A
A
R
T 
th
er
ap
y 
4–
6 
w
k 
af
te
r s
ta
rt
in
g 
an
tif
un
ga
l t
he
ra
py
.
Fo
r A
ID
S,
 f
lu
co
na
zo
le
 2
00
 m
g/
d 
un
til
 C
D
4 
> 
10
0/
μL
 a
nd
 u
nd
et
ec
ta
bl
e 
H
IV
 R
N
A
 v
ir
al
 lo
ad
 s
us
ta
in
ed
 fo
r 3
 m
o.
Fo
r s
ol
id
 o
rg
an
 tr
an
sp
la
nt
 r
ec
ip
ie
nt
s,
 tr
ea
t a
ll 
cr
yp
to
co
cc
os
is
 a
nd
 r
ed
uc
e 
im
m
un
os
up
pr
es
si
ve
 th
er
ap
y;
 c
on
si
de
r l
ow
er
in
g 
co
rt
ic
os
te
ro
id
 d
os
e 
fi
rs
t.
 
C
he
ck
 s
us
ce
pt
ib
ili
ty
 o
f p
er
si
st
en
t o
r r
el
ap
se
 is
ol
at
es
 a
ga
in
st
 th
e 
or
ig
in
al
 is
ol
at
e.
C
N
S 
or
 d
iss
em
in
at
ed
A
m
B
-d
 p
lu
s 
5-
FC
 fo
r 2
 w
k,
 
th
en
 f
lu
co
na
zo
le
 
fo
r m
in
im
um
 8
 w
k;
 
tr
ea
t f
or
 6
–1
8 
m
o 
fo
r c
er
eb
ra
l 
cr
yp
to
co
cc
om
a
Fl
uc
on
az
ol
e 
fo
r 1
0–
12
 w
k 
fo
r m
ild
-t
o-
m
od
er
at
e 
di
se
as
e;
L-
A
m
B
 fo
r 6
–1
0 
w
k;
L-
A
m
B
 p
lu
s 
5-
FC
 fo
r 
2 
w
k,
 th
en
 f
lu
co
na
zo
le
 fo
r 
m
in
im
um
 8
 w
k;
A
m
B-
d 
pl
us
 fl
uc
on
az
ol
e 
fo
r 2
 w
k,
 th
en
 f
lu
co
na
zo
le
 
fo
r m
in
im
um
 8
 w
k;
 
fl
uc
on
az
ol
e 
pl
us
 5
-F
C
 fo
r 
6 
w
k;
 it
ra
co
na
zo
le
 fo
r 
10
–1
2 
w
k;
 v
or
ic
on
az
ol
e
M
an
ag
em
en
t o
f e
le
va
te
d 
in
tr
ac
ra
ni
al
 p
re
ss
ur
e 
w
ith
 s
ym
pt
om
s.
K
ee
p 
in
iti
al
 C
SF
 o
pe
ni
ng
 p
re
ss
ur
e 
< 
20
0 
m
m
H
2O
1.
  If
 C
SF
 o
pe
ni
ng
 p
re
ss
ur
e 
≥ 
25
0 
m
m
 H
2O
, s
er
ia
l l
um
ba
r d
ra
in
ag
e 
to
 a
ch
ie
ve
 c
lo
si
ng
 
pr
es
su
re
 <
 2
00
 m
m
H
2O
 o
r 5
0%
 o
f i
ni
tia
l o
pe
ni
ng
 p
re
ss
ur
e;
2.
  If
 C
SF
 o
pe
ni
ng
 p
re
ss
ur
e 
< 
20
0 
m
m
 H
2O
, i
ni
tia
te
 m
ed
ic
al
 th
er
ap
y 
an
d 
fo
llo
w
 u
p 
lu
m
ba
r 
pu
nc
tu
re
 a
t s
ec
on
d 
w
k,
 o
r e
ar
lie
r a
s 
cl
in
ic
al
ly
 in
di
ca
te
d.
Fo
llo
w
-u
p 
fo
r e
le
va
te
d 
pr
es
su
re
, i
f e
le
va
te
d 
pr
es
su
re
 p
er
si
st
s.
1.
 R
ep
ea
te
d 
dr
ai
na
ge
 u
nt
il 
op
en
in
g 
pr
es
su
re
 is
 s
ta
bl
e.
2.
 P
er
cu
ta
ne
ou
s 
lu
m
ba
r d
ra
in
, v
en
tr
ic
ul
os
to
m
y.
3.
 V
en
tr
ic
ul
op
er
ito
ne
al
 s
hu
nt
.
Pn
eu
m
on
ia
 a
nd
 
ot
he
rs
A
m
B
-d
;
fl
uc
on
az
ol
e 
w
ith
 o
r 
w
ith
ou
t 5
-F
C
;
It
ra
co
na
zo
le
;
vo
ric
on
az
ol
e
Tr
ea
t f
or
 6
–1
2 
m
o 
fo
r i
m
m
un
oc
om
pe
te
nt
 p
at
ie
nt
s.
 
Fo
r i
m
m
un
oc
om
pr
om
iz
ed
 p
at
ie
nt
s,
 tr
ea
t a
s 
di
ss
em
in
at
ed
 in
fe
ct
io
n.
 263
Pu
lm
on
ar
y 
cr
yp
to
co
cc
om
a 
in
 
im
m
un
oc
om
pe
te
nt
 p
at
ie
nt
s
N
o 
th
er
ap
y,
 o
r 
fl
uc
on
az
ol
e 
20
0–
40
0 
m
g/
d 
po
 
–
N
o 
th
er
ap
y 
an
d 
cl
os
e 
ob
se
rv
at
io
n 
if 
se
ru
m
 a
nt
ig
en
 is
 
ne
ga
tiv
e.
5.
 P
ro
ph
yl
ax
is
In
va
si
ve
 c
an
di
di
as
is
N
ys
ta
tin
Fo
r l
eu
ke
m
ic
 p
at
ie
nt
s 
du
rin
g 
ch
em
ot
he
ra
py
. 
Fl
uc
on
az
ol
e
Li
m
it
ed
 to
 v
er
y 
hi
gh
-r
is
k 
pa
tie
nt
s 
su
ch
 a
s 
he
m
at
op
oi
et
ic
 s
te
m
 c
el
l t
ra
ns
pl
an
t r
ec
ip
ie
nt
s 
pr
io
r t
o 
en
gr
af
tm
en
t,
 s
ol
id
 o
rg
an
 tr
an
sp
la
nt
 r
ec
ip
ie
nt
s 
(l
iv
er
, p
an
cr
ea
s,
 s
m
al
l b
ow
el
).
A
sp
er
gi
llo
si
s
A
m
B
-d
;
itr
ac
on
az
ol
e;
ec
hi
no
ca
nd
in
Li
m
it
ed
 to
 v
er
y 
hi
gh
-r
is
k 
pa
tie
nt
s 
su
ch
 a
s 
al
lo
ge
ne
ic
 h
em
at
op
oi
et
ic
 s
te
m
 c
el
l t
ra
ns
pl
an
t 
re
ci
pi
en
ts
 p
rio
r t
o 
en
gr
af
tm
en
t,
 p
at
ie
nt
s 
w
ith
 G
VH
D
.
N
o 
da
ta
 a
va
ila
bl
e 
fo
r c
as
po
fu
ng
in
 a
nd
 a
ni
du
la
fu
ng
in
.
a A
lt
er
na
tiv
e 
(s
al
va
ge
) 
th
er
ap
y 
fo
r p
at
ie
nt
s 
re
fr
ac
to
ry
 to
, o
r i
nt
ol
er
an
t o
f, 
pr
im
ar
y 
th
er
ap
y;
 b
C
an
di
da
 c
ol
on
iz
at
io
n 
(p
ar
tic
ul
ar
ly
 a
t m
ul
tip
le
 s
it
es
),
 s
ev
er
ity
 o
f i
lln
es
s,
 n
um
be
r a
nd
 d
ur
at
io
n 
of
 
br
oa
d-
sp
ec
tr
um
 a
nt
ib
ac
te
ria
l a
ge
nt
s,
 s
ur
ge
ry
 (
es
pe
ci
al
ly
 b
ow
el
 s
ur
ge
ry
),
 d
ia
ly
si
s,
 c
en
tr
al
 v
en
ou
s 
ca
th
et
er
s,
 p
ar
en
te
ra
l n
ut
rit
io
n,
 a
nd
 le
ng
th
 o
f I
C
U
 s
ta
y 
ar
e 
im
po
rt
an
t r
is
k 
fa
ct
or
s 
fo
r i
nv
a-
si
ve
 c
an
di
di
as
is
; c
A
m
ph
ot
er
ic
in
 B
 d
eo
xy
ch
ol
at
e 
0.
5–
1.
0 
m
g/
kg
/d
 fo
r i
nv
as
iv
e 
ca
nd
id
ia
si
s,
 0
.7
–1
.0
 m
g/
kg
/d
 fo
r c
ry
pt
oc
oc
co
si
s,
 1
.0
–1
.5
m
g/
kg
/d
 fo
r i
nv
as
iv
e 
as
pe
rg
ill
os
is
 a
nd
 in
va
si
ve
 z
yg
o-
m
yc
os
is
; 
d I
nt
ra
ve
no
us
, 
or
 o
ra
l, 
fl
uc
on
az
ol
e 
80
0 
m
g 
(1
2 
m
g/
kg
) 
on
 D
ay
 1
 (
lo
ad
in
g)
, 
th
en
 4
00
 m
g 
(6
 m
g/
kg
) 
da
ily
 f
or
 in
va
si
ve
 c
an
di
di
as
is
, 
40
0–
80
0 
m
g 
(1
0–
15
 m
g/
kg
) 
da
ily
 f
or
 C
N
S 
cr
yp
to
co
cc
os
is
; e
C
as
po
fu
ng
in
 7
0 
m
g 
(l
oa
di
ng
) 
th
en
 5
0 
m
g 
da
ily
; m
ic
af
un
gi
n:
 1
00
 m
g 
da
ily
; a
ni
du
la
fu
ng
in
: 2
00
 m
g 
(l
oa
di
ng
),
 th
en
 1
00
 m
g 
da
ily
; f
L-
A
m
B
 3
–5
 m
g/
kg
 d
ai
ly
 fo
r i
nv
as
iv
e 
ca
n-
di
di
as
is
 a
nd
 in
va
si
ve
 a
sp
er
gi
llo
si
s,
 4
–6
 m
g/
kg
/d
 fo
r 
cr
yp
to
co
cc
os
is
; 3
–1
0 
m
g/
kg
/d
 fo
r 
in
va
si
ve
 z
yg
om
yc
os
is
; g
In
tr
av
en
ou
s,
 o
r 
or
al
, v
or
ic
on
az
ol
e 
40
0 
m
g 
(6
 m
g/
kg
) 
ev
er
y 
12
 h
ou
rs
 fo
r 
tw
o 
do
se
s 
on
 D
ay
 1
 (
lo
ad
in
g)
, t
he
n 
20
0 
m
g 
(3
–4
 m
g/
kg
) 
bi
d;
 h
D
os
ag
e 
of
 it
ra
co
na
zo
le
 fo
r t
re
at
m
en
t o
f i
nv
as
iv
e 
pu
lm
on
ar
y 
as
pe
rg
ill
os
is
 d
ep
en
ds
 o
n 
th
e 
fo
rm
ul
at
io
n.
 T
he
 d
os
ag
e 
fo
r t
ab
le
ts
 is
 
60
0 
m
g/
d 
fo
r 
3 
da
ys
, f
ol
lo
w
ed
 b
y 
40
0 
m
g/
da
y.
 A
lt
ho
ug
h 
us
ed
 in
 s
om
e 
ca
se
 r
ep
or
ts
, o
ra
l s
ol
ut
io
ns
 a
re
 n
ot
 li
ce
ns
ed
 fo
r 
tr
ea
tm
en
t 
of
 in
va
si
ve
 a
sp
er
gi
llo
si
s.
 A
 p
ar
en
te
ra
l f
or
m
ul
at
io
n 
ha
s 
be
en
 s
tu
di
ed
 in
 a
 li
m
it
ed
 s
er
ie
s 
us
in
g 
a 
do
sa
ge
 o
f 2
00
 m
g 
iv
 e
ve
ry
 1
2 
ho
ur
s 
fo
r 2
 d
ay
s,
 fo
llo
w
ed
 b
y 
20
0 
m
g 
da
ily
 th
er
ea
ft
er
 (
w
he
th
er
 th
is
 is
 a
n 
op
ti
m
al
 d
os
ag
e 
ha
s 
no
t b
ee
n 
de
fi
ne
d)
; i
Fl
u-
cy
to
si
ne
 2
5 
m
g/
kg
 4
 ti
m
es
 d
ai
ly
 fo
r p
at
ie
nt
s 
w
ith
 n
or
m
al
 r
en
al
 fu
nc
tio
n 
an
d 
is
 r
ar
el
y 
ad
m
in
is
te
re
d 
as
 a
 s
in
gl
e 
ag
en
t;
 j S
-D
D
 s
us
ce
pt
ib
le
 d
os
e 
de
pe
nd
en
t.
 A
m
B
-d
 =
 D
eo
xy
ch
ol
at
e 
am
ph
ot
er
-
ic
in
 B
; C
. p
ar
ap
sil
os
is 
= 
C
an
di
da
 p
ar
ap
sil
os
is;
 C
. g
la
br
at
a 
= 
C
an
di
da
 g
la
br
at
a;
 C
. k
ru
se
i =
 C
an
di
da
 k
ru
se
i; 
iv
 =
 in
tr
av
en
ou
s;
 p
o 
= 
or
al
ly
; C
N
S 
= 
ce
nt
ra
l n
er
vo
us
 s
ys
te
m
; A
ID
S 
= 
ac
ut
e 
im
m
un
od
ef
ic
ie
nc
y 
di
se
as
es
; H
A
A
R
T 
= 
hi
gh
ly
 a
ct
iv
e 
an
tir
et
ro
vi
ra
l t
he
ra
py
; H
IV
 =
 h
um
an
 im
m
un
od
ef
ic
ie
nc
y 
vi
ru
s;
 C
SF
 =
 ce
re
br
os
pi
na
l f
lu
id
; L
-A
m
B
 =
 li
po
so
m
al
 a
m
ph
ot
er
ic
in
 B
.
